CR20140374A - Nuevos usos pediatricos del cabazitaxel - Google Patents
Nuevos usos pediatricos del cabazitaxelInfo
- Publication number
- CR20140374A CR20140374A CR20140374A CR20140374A CR20140374A CR 20140374 A CR20140374 A CR 20140374A CR 20140374 A CR20140374 A CR 20140374A CR 20140374 A CR20140374 A CR 20140374A CR 20140374 A CR20140374 A CR 20140374A
- Authority
- CR
- Costa Rica
- Prior art keywords
- cabazitaxel
- pediatric uses
- new pediatric
- new
- compound
- Prior art date
Links
- BMQGVNUXMIRLCK-OAGWZNDDSA-N cabazitaxel Chemical compound O([C@H]1[C@@H]2[C@]3(OC(C)=O)CO[C@@H]3C[C@@H]([C@]2(C(=O)[C@H](OC)C2=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=3C=CC=CC=3)C[C@]1(O)C2(C)C)C)OC)C(=O)C1=CC=CC=C1 BMQGVNUXMIRLCK-OAGWZNDDSA-N 0.000 title 1
- 229960001573 cabazitaxel Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Epoxy Compounds (AREA)
Abstract
La presente invención se refiere al compuesto de fórmula (I):
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12305151 | 2012-02-10 | ||
| EP12306352 | 2012-10-30 | ||
| PCT/EP2013/052518 WO2013117683A1 (en) | 2012-02-10 | 2013-02-08 | New pediatric uses of cabazitaxel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20140374A true CR20140374A (es) | 2014-12-01 |
Family
ID=47714075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20140374A CR20140374A (es) | 2012-02-10 | 2014-08-07 | Nuevos usos pediatricos del cabazitaxel |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20140350273A1 (es) |
| EP (1) | EP2811996A1 (es) |
| JP (1) | JP2015509929A (es) |
| KR (1) | KR20140129091A (es) |
| CN (1) | CN104334172A (es) |
| AU (1) | AU2013217964A1 (es) |
| BR (1) | BR112014019675A2 (es) |
| CA (1) | CA2864029A1 (es) |
| CL (1) | CL2014002118A1 (es) |
| CO (1) | CO7030963A2 (es) |
| CR (1) | CR20140374A (es) |
| EA (1) | EA201491506A1 (es) |
| GT (1) | GT201400173A (es) |
| HK (1) | HK1199398A1 (es) |
| IL (1) | IL234015A0 (es) |
| MX (1) | MX2014009610A (es) |
| NZ (1) | NZ628565A (es) |
| PH (1) | PH12014501794A1 (es) |
| SG (1) | SG11201404712UA (es) |
| WO (1) | WO2013117683A1 (es) |
| ZA (1) | ZA201405815B (es) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6346543B1 (en) * | 1998-08-17 | 2002-02-12 | Aventis Pharma S.A. | Use of a taxoid to treat abnormal cell proliferation in the brain |
| FR2859996B1 (fr) * | 2003-09-19 | 2006-02-03 | Aventis Pharma Sa | Solvat acetonique du dimethoxy docetaxel et son procede de preparation |
| BR112012012210B8 (pt) * | 2009-11-23 | 2021-05-25 | Cerulean Pharma Inc | conjugado de (cdp)-taxano de polímero contendo ciclodextrina, composição, composição farmacêutica, forma de dosagem, kit e uso de um conjugado de cdp-taxano |
-
2013
- 2013-02-08 WO PCT/EP2013/052518 patent/WO2013117683A1/en not_active Ceased
- 2013-02-08 AU AU2013217964A patent/AU2013217964A1/en not_active Abandoned
- 2013-02-08 BR BR112014019675A patent/BR112014019675A2/pt not_active IP Right Cessation
- 2013-02-08 HK HK14112919.7A patent/HK1199398A1/xx unknown
- 2013-02-08 EA EA201491506A patent/EA201491506A1/ru unknown
- 2013-02-08 KR KR20147024757A patent/KR20140129091A/ko not_active Withdrawn
- 2013-02-08 JP JP2014556069A patent/JP2015509929A/ja active Pending
- 2013-02-08 EP EP13704072.1A patent/EP2811996A1/en not_active Withdrawn
- 2013-02-08 MX MX2014009610A patent/MX2014009610A/es unknown
- 2013-02-08 CN CN201380019076.2A patent/CN104334172A/zh active Pending
- 2013-02-08 CA CA2864029A patent/CA2864029A1/en not_active Abandoned
- 2013-02-08 SG SG11201404712UA patent/SG11201404712UA/en unknown
- 2013-02-08 NZ NZ628565A patent/NZ628565A/en not_active IP Right Cessation
-
2014
- 2014-08-07 IL IL234015A patent/IL234015A0/en unknown
- 2014-08-07 ZA ZA2014/05815A patent/ZA201405815B/en unknown
- 2014-08-07 CR CR20140374A patent/CR20140374A/es unknown
- 2014-08-07 US US14/454,364 patent/US20140350273A1/en not_active Abandoned
- 2014-08-07 GT GT201400173A patent/GT201400173A/es unknown
- 2014-08-08 CO CO14172855A patent/CO7030963A2/es unknown
- 2014-08-08 PH PH12014501794A patent/PH12014501794A1/en unknown
- 2014-08-08 CL CL2014002118A patent/CL2014002118A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015509929A (ja) | 2015-04-02 |
| WO2013117683A1 (en) | 2013-08-15 |
| KR20140129091A (ko) | 2014-11-06 |
| BR112014019675A2 (pt) | 2017-07-11 |
| NZ628565A (en) | 2016-03-31 |
| AU2013217964A1 (en) | 2014-08-28 |
| CN104334172A (zh) | 2015-02-04 |
| SG11201404712UA (en) | 2014-09-26 |
| EP2811996A1 (en) | 2014-12-17 |
| EA201491506A1 (ru) | 2014-12-30 |
| HK1199398A1 (zh) | 2015-07-03 |
| MX2014009610A (es) | 2015-09-25 |
| GT201400173A (es) | 2015-08-13 |
| CL2014002118A1 (es) | 2015-06-26 |
| CO7030963A2 (es) | 2014-08-21 |
| PH12014501794A1 (en) | 2014-11-24 |
| US20140350273A1 (en) | 2014-11-27 |
| ZA201405815B (en) | 2015-11-25 |
| CA2864029A1 (en) | 2013-08-15 |
| IL234015A0 (en) | 2014-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20140510A (es) | Nucleósidos de espirooxetano de uracilo | |
| JOP20180103A1 (ar) | مركب صيدلاني | |
| CR20140042A (es) | Indazoles | |
| CY1119105T1 (el) | Παραγωγα διπυραζολιου ως αναστολεις jak | |
| CR20140132A (es) | Derivados de pirrolopirimidina y purina | |
| CR20140463A (es) | Compuestos de heterociclilo como inhibidores de mek | |
| CR20150271A (es) | Peptidos como agonistas de oxitocina | |
| CR20150084A (es) | 2-oxo-2,3-dihidro-indoles | |
| EA201790963A1 (ru) | Противовирусные соединения | |
| CR20140535A (es) | Novedosas n-piridinil amidas cíclicas sustituidas como inhibidores de quinasa | |
| CR20140435A (es) | Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos | |
| CR20130129A (es) | Anàlogos de buprenorfina | |
| CR20140468A (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
| ECSP14013327A (es) | Compuestos con actividad nematicida | |
| EA201491817A1 (ru) | Терапевтическое применение продуктов из косточек винограда шардоне | |
| CR20150069A (es) | Pirrolopirazoles como bloqueadores del canal de calcio tipo n | |
| CR20140094A (es) | Derivados de etinilo | |
| ECSP13012366A (es) | Procedimiento de preparación de la sal de l-arginina de perindoprilo | |
| CR20140322A (es) | Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2 | |
| CR20150087A (es) | Derivados de pirazol-carboxamida | |
| CR20130475A (es) | Derivados de etinilo | |
| CU20150006A7 (es) | Derivados de (piperidin-4-il)piperazina-1-carboxamida/carboxilato útiles como antagonistas del receptor -h3 | |
| CR20150144A (es) | Derivados de etinilo como moduladores del receptor de actividad mglur5 | |
| CR20140124A (es) | Metabolitos de transclomifeno y usos de los mismos | |
| JOP20180012A1 (ar) | عملية السلفنة باستخدام نونافلوروبوتانيسولفونيل فلوريد |